3D Segmentation of Pathological Muscle with a Physics-Informed Latent-Regularized U-Net
En palabras de los autores
ObjectiveWe developed a data-efficient deep learning framework for three-dimensional segmentation of pathological musculoskeletal anatomy from magnetic resonance imaging (MRI) when only limited manual annotations are available. MethodsWe developed a Physics-Informed Latent-Regularized U-Net (PILR-U-Net) that combines transfer learning from healthy MRI, latent-space anatomical regularization, and elasticity-based physics-informed constraints. The physics-informed loss enforces mechanical equilibrium, near-incompressibility, and spatial smoothness of predicted deformation fields. The framework was evaluated on MRI datasets from 50 participants with cerebral palsy across 15 lower-limb musculoskeletal structures using sparse manual annotations. Performance was assessed using volumetric overlap, boundary accuracy, volume error, sensitivity, and precision. Ablation experiments evaluated the individual contributions of latent-space and physics-informed regularization. ResultsOur experimental results show accurate segmentations with three-dimensional Dice coefficients ranging from 0.750 to 0.943 across evaluated structures, while most structures exhibited low surface-distance errors. Predicted deformation fields maintained positive Jacobian determinants near unity and smooth strain-energy distributions. Ablation analysis showed that both regularization components improved performance, with removal of physics-informed regularization producing the largest reductions in Dice accuracy and increases in boundary error. ConclusionPILR-U-Net enables accurate and anatomically plausible segmentation of pathological musculoskeletal MRI under sparse supervision. SignificanceIncorporating anatomical priors and biomechanical constraints into deep segmentation networks may reduce dependence on extensive pathological annotations and support patient-specific musculoskeletal modeling and clinical analysis.
Apareció: martes, 22 de septiembre. medRxiv. Preprint, todavía sin revisión por pares.